Cite

HARVARD Citation

    Saberian, C. et al. (n.d.). 657 Interleukin-6 receptor blockade for management of immune checkpoint inhibitor related adverse events in patients with melanoma. Journal for immunotherapy of cancer. p. A394. [Online]. 
  
Back to record